Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase-or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?

ANTONIO RIVERO ROMÁN2026-01-292026-01-29202010.1093/jac/dkz4212-s2.0-85076449170https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/31123Infectious DiseasesMicrobiology (medical)PharmacologyPharmacology (medical)Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase-or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?research article